432 related articles for article (PubMed ID: 9878608)
1. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein.
Lukac DM; Renne R; Kirshner JR; Ganem D
Virology; 1998 Dec; 252(2):304-12. PubMed ID: 9878608
[TBL] [Abstract][Full Text] [Related]
2. Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator.
Chen J; Ueda K; Sakakibara S; Okuno T; Parravicini C; Corbellino M; Yamanishi K
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4119-24. PubMed ID: 11274437
[TBL] [Abstract][Full Text] [Related]
3. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
Lan K; Murakami M; Choudhuri T; Kuppers DA; Robertson ES
Virology; 2006 Aug; 351(2):393-403. PubMed ID: 16701788
[TBL] [Abstract][Full Text] [Related]
4. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.
Liang Y; Ganem D
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8490-5. PubMed ID: 12832621
[TBL] [Abstract][Full Text] [Related]
5. Alternatively initiated gene 50/RTA transcripts expressed during murine and human gammaherpesvirus reactivation from latency.
Gray KS; Allen RD; Farrell ML; Forrest JC; Speck SH
J Virol; 2009 Jan; 83(1):314-28. PubMed ID: 18971285
[TBL] [Abstract][Full Text] [Related]
6. Lytic cycle switches of oncogenic human gammaherpesviruses.
Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
[TBL] [Abstract][Full Text] [Related]
7. Prostratin and bortezomib are novel inducers of latent Kaposi's sarcoma-associated herpesvirus.
Brown HJ; McBride WH; Zack JA; Sun R
Antivir Ther; 2005; 10(6):745-51. PubMed ID: 16218174
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.
Sakakibara S; Ueda K; Nishimura K; Do E; Ohsaki E; Okuno T; Yamanishi K
J Virol; 2004 Jul; 78(14):7299-310. PubMed ID: 15220403
[TBL] [Abstract][Full Text] [Related]
9. In primary effusion lymphoma cells, MYB transcriptional repression is associated with v-FLIP expression during latent KSHV infection while both v-FLIP and v-GPCR become involved during the lytic cycle.
Lacoste V; Nicot C; Gessain A; Valensi F; Gabarre J; Matta H; Chaudhary PM; Mahieux R
Br J Haematol; 2007 Aug; 138(4):487-501. PubMed ID: 17659053
[TBL] [Abstract][Full Text] [Related]
10. Notch signal transduction induces a novel profile of Kaposi's sarcoma-associated herpesvirus gene expression.
Chang H
J Microbiol; 2006 Apr; 44(2):217-25. PubMed ID: 16728959
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
[TBL] [Abstract][Full Text] [Related]
12. DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters.
Lukac DM; Garibyan L; Kirshner JR; Palmeri D; Ganem D
J Virol; 2001 Aug; 75(15):6786-99. PubMed ID: 11435557
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells.
Lukac DM; Kirshner JR; Ganem D
J Virol; 1999 Nov; 73(11):9348-61. PubMed ID: 10516043
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters.
Jeong J; Papin J; Dittmer D
J Virol; 2001 Feb; 75(4):1798-807. PubMed ID: 11160678
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus.
Cathomas G
Herpes; 2003 Dec; 10(3):72-7. PubMed ID: 14759339
[TBL] [Abstract][Full Text] [Related]
16. Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays.
Dittmer DP
Cancer Res; 2003 May; 63(9):2010-5. PubMed ID: 12727810
[TBL] [Abstract][Full Text] [Related]
17. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
18. Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Targeting of a dCas9-Based Transcription Activator to the ORF50 Promoter.
Elbasani E; Falasco F; Gramolelli S; Nurminen V; Günther T; Weltner J; Balboa D; Grundhoff A; Otonkoski T; Ojala PM
Viruses; 2020 Aug; 12(9):. PubMed ID: 32867368
[TBL] [Abstract][Full Text] [Related]
19. Transcription pattern of human herpesvirus 8 open reading frame K3 in primary effusion lymphoma and Kaposi's sarcoma.
Rimessi P; Bonaccorsi A; Stürzl M; Fabris M; Brocca-Cofano E; Caputo A; Melucci-Vigo G; Falchi M; Cafaro A; Cassai E; Ensoli B; Monini P
J Virol; 2001 Aug; 75(15):7161-74. PubMed ID: 11435597
[TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis.
Viejo-Borbolla A; Schulz TF
AIDS Rev; 2003; 5(4):222-9. PubMed ID: 15012001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]